
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. (ORIC)
WebsitePrice
Market cap
Next catalystExpected 1H 2027Enozertinib — Redwood-1 planned Phase 3 monotherapy · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
PreINDP1P2FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2FilingApproved
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved